TRAW
Traws Pharma, Inc.- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.60
- As of
Share the TRAW intelligence card
See TRAW live in the terminal
Track TRAW's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live TRAW terminal, freeActive signals for TRAW
- mediumEARNINGS_BEAT
Q4-2024: Beat consensus by 1082.0% - EPS $95.66 vs $-9.741 estimate
- mediumEARNINGS_BEAT
Beat consensus by 1082.0% - EPS $95.66 vs $-9.741 estimate
- mediumEARNINGS_BEAT
Q4-2025: Beat consensus by 150.5% - EPS $0.63 vs $-1.2485 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 29.8% - EPS $-0.53 vs $-0.7548 estimate
- mediumEARNINGS_MISS
Q3-2024: Missed consensus by 41.0% - EPS $-8.81 vs $-6.2475 estimate
Top institutional holders of TRAW (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | $41K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $35K | 0.00% | +0.0% |
| CITADEL ADVISORS LLC | $28K | 0.00% | , |
| TWO SIGMA INVESTMENTS, LP | $22K | 0.00% | -12.6% |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, TRAW
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Catch the next move on names like this
New 13F filings, insider trades, and cross asset signals like the ones above, in your inbox each morning or live on Telegram. Free, no account.
One email a day. Unsubscribe anytime. We never sell your data.
See more TRAW signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to TRAWand get the insider, 13F, options, and confluence read in one view.